Seikagaku08.10.21
Seikagaku Corporation has launched HyLink, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Taiwan, through TCM Biotech International Corp.
HyLink’s main ingredient is a cross-linked hyaluronate hydrogel made using Seikagaku’s unique crosslinking technology. Since the highly viscoelastic hyaluronate hydrogel remains in the knee joint cavity for a long period of time, HyLink is expected a long-lasting improvement of symptoms by an administration of only 3 mL .
TCM is a pharmaceutical company with a nationwide sales network in Taiwan that has strengths in the fields of orthopedics and rehabilitation. TCM exclusively distributes in Taiwan ARTZDispo1 and Artzfors2 , intra-articular multiple-injection viscosupplements manufactured by Seikagaku. These products hold a high share in the Taiwanese market for hyaluronic acid treatments, which is expected to expand as the elderly population grows, and TCM will aim to further strengthen its presence in the market by introducing HyLink in addition to ARTZDispo and Artzfors.
Seikagaku will continue to support TCM’s sales promotion activities through the provision of academic information in its capacity as manufacturer, and Seikagaku and TCM together will contribute to improving the quality of life of patients.
References
1 ARTZDispo: A medical device indicated for knee osteoarthritis and rotator cuff lesions without complete tears
2 Artzfors: A medical device indicated for rotator cuff lesions without complete tears
HyLink’s main ingredient is a cross-linked hyaluronate hydrogel made using Seikagaku’s unique crosslinking technology. Since the highly viscoelastic hyaluronate hydrogel remains in the knee joint cavity for a long period of time, HyLink is expected a long-lasting improvement of symptoms by an administration of only 3 mL .
TCM is a pharmaceutical company with a nationwide sales network in Taiwan that has strengths in the fields of orthopedics and rehabilitation. TCM exclusively distributes in Taiwan ARTZDispo1 and Artzfors2 , intra-articular multiple-injection viscosupplements manufactured by Seikagaku. These products hold a high share in the Taiwanese market for hyaluronic acid treatments, which is expected to expand as the elderly population grows, and TCM will aim to further strengthen its presence in the market by introducing HyLink in addition to ARTZDispo and Artzfors.
Seikagaku will continue to support TCM’s sales promotion activities through the provision of academic information in its capacity as manufacturer, and Seikagaku and TCM together will contribute to improving the quality of life of patients.
References
1 ARTZDispo: A medical device indicated for knee osteoarthritis and rotator cuff lesions without complete tears
2 Artzfors: A medical device indicated for rotator cuff lesions without complete tears